CO7141425A2 - Ophthalmic compositions with improved retention and drying protection - Google Patents

Ophthalmic compositions with improved retention and drying protection

Info

Publication number
CO7141425A2
CO7141425A2 CO14260442A CO14260442A CO7141425A2 CO 7141425 A2 CO7141425 A2 CO 7141425A2 CO 14260442 A CO14260442 A CO 14260442A CO 14260442 A CO14260442 A CO 14260442A CO 7141425 A2 CO7141425 A2 CO 7141425A2
Authority
CO
Colombia
Prior art keywords
compositions
ophthalmic compositions
improved retention
drying protection
present
Prior art date
Application number
CO14260442A
Other languages
Spanish (es)
Inventor
James W Davis
Howard Allen Ketelson
Elaine E Campbell
David Meadows
Rekha Rangarajan
Original Assignee
Alcon Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Res Ltd filed Critical Alcon Res Ltd
Publication of CO7141425A2 publication Critical patent/CO7141425A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a composiciones de lágrimasartificiales y composiciones oftálmicas adecuadas para laadministración de fármacos. En una modalidad de la presenteinvención, las composiciones comprenden un polímero degalactomanano tal como guar o hidroxipropil guar, ácidohialurónico y un cis-diol tal como sorbitol. En una modalidadpreferida, las composiciones también comprenden un compuestode borato.The present invention relates to artificial tear compositions and ophthalmic compositions suitable for drug administration. In one embodiment of the present invention, the compositions comprise a polymer of galactomannan such as guar or hydroxypropyl guar, hyaluronic acid and a cis-diol such as sorbitol. In a preferred embodiment, the compositions also comprise a borate compound.

CO14260442A 2012-05-04 2014-11-26 Ophthalmic compositions with improved retention and drying protection CO7141425A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261642902P 2012-05-04 2012-05-04

Publications (1)

Publication Number Publication Date
CO7141425A2 true CO7141425A2 (en) 2014-12-12

Family

ID=52471441

Family Applications (1)

Application Number Title Priority Date Filing Date
CO14260442A CO7141425A2 (en) 2012-05-04 2014-11-26 Ophthalmic compositions with improved retention and drying protection

Country Status (1)

Country Link
CO (1) CO7141425A2 (en)

Similar Documents

Publication Publication Date Title
AR090930A1 (en) OPHTHALM COMPOSITIONS WITH IMPROVED PROTECTION AGAINST DESECTION AND RETENTION
AR112286A2 (en) POLYMERIC SYSTEM OF ARTIFICIAL TEARS
GT201400300A (en) SYRINGE
NI201500036A (en) THERAPEUTIC NANOPARTICLES INCLUDING A THERAPEUTIC AGENT AND METHODS TO MAKE THEM AND USE THEM.
EA201690780A1 (en) PEDIATED MEDICINE-LINKS FOR IMPROVED PHARMACOKINETICS OF LJAND-MEDICINE CONJUGATES
PH12015500850A1 (en) Stable preservative-free mydriatic and anti-inflammatory solutions for injection
BR112017007123A2 (en) tetrahydroisoquinoline derivatives
CL2013002134A1 (en) Topical administration ophthalmic pharmaceutical composition comprising an androgen; and method to treat an eye condition resulting from an androgen deficiency.
MY178680A (en) Hydrogel prodrugs
CR20150250A (en) NEW DERIVATIVES OF PIRIDINA
ECSP12012167A (en) Procedures for the formation of cyclodextrin complexes to formulate peptide proteasome inhibitors
WO2014153009A3 (en) Thiosaccharide mucolytic agents
BR112015008954A2 (en) alkylated cyclodextrin compositions and processes for their preparation and use
TR201910866T4 (en) Combined preparations for cancer treatment.
GT201500035A (en) ORAL PHARMACEUTICAL COMPOSITION IN THE FORM OF MICROSPHERES AND ELABORATION PROCESS
PH12016500465B1 (en) Deoxynojirimycin derivatives and methods of their using
TN2015000520A1 (en) Pharmaceutical compositions comprising collagen and sodium hyaluronate
BR112013008749A2 (en) cyclosporine analogs
CO6920289A2 (en) Topical ophthalmic pharmaceutical composition containing regorafenib.
MX2015013187A (en) Stable transdermal amphetamine compositions and methods of manufacture.
MX2016000294A (en) Pharmaceutical composition for a sustained release of lanreotide.
BR112014028006A2 (en) pyrrolidine heterocycles
AR092151A1 (en) SOLID PHARMACEUTICAL PREPARATION CONTAINING LEVOTIROXIN
PH12015500585A1 (en) Modified hyaluronic acid derivatives and use thereof
CY1122538T1 (en) CHONDROITIN COMPLEXES FOR TRANSCUTANEOUS ABSORPTION